We would like to welcome Dawn to the RenovoDerm team! Dawn Cornett, Director of Market Development, is a former VP of Clinical Sales at Genadyne Biotechnologies with over 20 years of experience within the healthcare field. Dawn was responsible for launching Genadyne Biotechnologies national hospital division. For 9 years, Dawn was the Executive Director of a durable medical equipment company’s wound care division. Most notably, she was responsible for achieving a multi-million-dollar division within her first two years of a new product launch. Additionally, Dawn achieved a yearly growth of over 30% and oversaw the acquisition of Wrencare’s wound division to Lincare. While at Lincare, she again launched a successful national wound care program.
Today, RenovoDerm announced that the U.S. Food and Drug Administration (FDA) has cleared its proprietary product, the Phoenix Wound Matrix, which is a wound care device that accelerates the body’s healing response, facilitates tissue growth and regeneration, reduces scar formation and enhances overall cosmesis.
The Phoenix Wound Matrix is a fully resorbable synthetic graft that closely mimics the extracellular matrix (ECM) found naturally in the body. This product will be used for the treatment of acute, chronic, and burn wounds, which continues to be a concern for both doctors and patients.
Pictured: RenovoDerm CTO Jed Johnson with Nanofiber Solutions' third fully issued patent from the United States Patent and Trademark Office.
RenovoDerm CTO Jed Johnson recently spoke at The World Stem Cell Summit on January 26th in Miami. He discussed the use of nanofiber scaffolds for tissue engineering in an RMMS technical session on bioprinting.
Jed Johnson represented RenovoDerm at the 2017 Heal Ohio Wound Care Conference on Thursday, November 2nd. Heal Ohio is a statewide collaborative that aims to unite scientists, healthcare professionals, and commercial partners who share a common vision and mission to solve problems associated with wound care. In doing this, it will serve to bridge the gaps that exist between clinics, research, business, and patients.
The 2017 Heal Ohio Conference was devoted to health professional presentations and feature informative learning sessions and keynote addresses. Activities provided an atmosphere rich in collaboration and networking for both career and research advancement.